Text Size
548 studies found for:    "Hypertension, Pulmonary"

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Recruiting Latent Pulmonary Hypertension (PH) in Chronic Thromboembolic Pulmonary Hypertension (CTEPH )After Endarterectomy and Influence of Exercise and Respiratory Therapy
Conditions: Pulmonary Hypertension;   Chronic Thromboembolic Pulmonary Hypertension
Interventions: Behavioral: exercise and respiratory therapy;   Other: sedentary control group
2 Unknown † Simvatstatin Used to Treat Pulmonary Hypertension
Condition: Hypertension, Pulmonary
Intervention: Drug: simvastatin
3 Unknown † Study of Dehydroepiandrosterone (DHEA) in Respiratory Pulmonary Hypertension in Adults
Conditions: Chronic Obstructive Pulmonary Disease;   Hypertension, Pulmonary
Intervention: Drug: DHEA Treatment
4 Recruiting Study of Dehydroepiandrosterone (DHEA) in Respiratory Pulmonary Hypertension in Adults
Conditions: Chronic Obstructive Pulmonary Disease;   Hypertension, Pulmonary
Interventions: Drug: DHEA treatment;   Drug: Placebo
5 Unknown † Safety and Efficacy of Bosentan in Patients With Diastolic Heart Failure and Secondary Pulmonary Hypertension
Conditions: Heart Failure, Diastolic;   Hypertension, Pulmonary
Interventions: Drug: bosentan;   Drug: placebo
6 Completed Sildenafil to Improve Exercise Capacity in People With Thalassemia and Pulmonary Hypertension
Conditions: Thalassemia;   Hypertension, Pulmonary
Intervention: Drug: Sildenafil
7 Recruiting Aerobic Exercise in Patients With Pulmonary Hypertension
Condition: Hypertension, Pulmonary
Interventions: Procedure: Excerise Training;   Procedure: Patient Education (Placebo)
8 Completed Sildenafil to Increase Exercise Capacity in Individuals With Idiopathic Pulmonary Fibrosis and Pulmonary Hypertension
Conditions: Pulmonary Fibrosis;   Hypertension, Pulmonary
Intervention: Drug: Sildenafil (50 mg)
9 Completed Aerosolized Randomized Iloprost Study II (AIR - II) Long-Term Safety, Tolerability, and Clinical Effects of Iloprost Inhalation in Patients With Primary or Secondary Pulmonary Hypertension
Condition: Hypertension, Pulmonary
Intervention: Drug: Ventavis (Iloprost, BAYQ6256)
10 Completed A Study to Test the Effects of Riociguat in Patients With Pulmonary Hypertension Associated With Left Ventricular Diastolic Dysfunction
Conditions: Hypertension, Pulmonary;   Ventricular Dysfunction, Left
Interventions: Drug: Riociguat (BAY63-2521);   Drug: Placebo
11 Completed Observation of Patients With Primary Pulmonary Hypertension Receiving Prescribed Ventavis Inhalation Therapy Regarding Safety and Efficacy for up to 4 Years
Condition: Hypertension, Pulmonary
Intervention: Drug: Iloprost (Ventavis, BAYQ6256)
12 Active, not recruiting A Study to Test the Effects of Riociguat in Patients With Pulmonary Hypertension Associated With Left Ventricular Systolic Dysfunction
Conditions: Hypertension, Pulmonary;   Ventricular Dysfunction, Left
Interventions: Drug: Riociguat (BAY63-2521);   Drug: Placebo
13 Completed Single Dose Study in Patients With Chronic Obstructive Pulmonary Disease (COPD) Associated Pulmonary Hypertension.
Conditions: Hypertension, Pulmonary;   Pulmonary Disease, Chronic Obstructive
Intervention: Drug: Riociguat (BAY63-2521)
14 Active, not recruiting Impact of Multiple Doses of BAY63-2521 on Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Patients With Interstitial Lung Disease (ILD) Associated Pulmonary Hypertension (PH)
Condition: Hypertension, Pulmonary
Intervention: Drug: Riociguat (BAY63-2521)
15 Enrolling by invitation Right Ventricular Resynchronization Therapy
Conditions: Right Ventricular Failure;   Chronic Thromboembolic Pulmonary Hypertension;   Pulmonary Hypertension
Intervention: Device: Implantation of 3-chamber pacemaker
16 Completed Atorvastatin in Pulmonary Hypertension
Condition: Hypertension, Pulmonary
Interventions: Drug: Atorvastatin;   Drug: Placebo
17 Completed Safety Follow-up Study of Inhaled Iloprost in Patients With Pulmonary Hypertension
Condition: Hypertension, Pulmonary
Intervention: Drug: Ventavis (Iloprost, BAYQ6256)
18 Terminated Study of the Efficacy and Safety of Tezosentan in Patients With Pre-operative Pulmonary Hypertension, Due to Left Heart Disease, Undergoing Open Heart Surgery
Conditions: Heart Diseases;   Hypertension, Pulmonary
Interventions: Drug: tezosentan;   Drug: placebo
19 Not yet recruiting Targeting the Right Ventricle in Pulmonary Hypertension
Condition: Pulmonary Hypertension
Interventions: Drug: Ranolazine;   Drug: Placebo
20 Unknown † The Role of Endothelin in Pulmonary Hypertension
Condition: Pulmonary Hypertension
Intervention: Drug: BQ-123
To Top

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
† Indicates status has not been verified in more than two years